Journal article · 2023 · Open access

Glutathione‐Scavenging Nanoparticle‐Mediated PROTACs Delivery for Targeted Protein Degradation and Amplified Antitumor Effects

Haijun Liu, Wei Chen, Gongwei Wu, Jun Min Zhou, Chuang LIU, Zhongmin Tang, Xiangang Huang, Jingjing Gao, Yufen Xiao, Na Kong, Nitin Joshi, Yihai Cao and 2 more

Advanced Science, 10(16), e2207439 · Published 17 April 2023 · DOI 10.1002/advs.202207439

Open PDFView at the publisherCite this paper

In brief

“Glutathione‐Scavenging Nanoparticle‐Mediated PROTACs Delivery for Targeted Protein Degradation and Amplified Antitumor Effects” is a 2023 journal article by Haijun Liu and 13 co-authors, published in Advanced Science. OpenAlex counts 121 citations as of 22 November 2026, which puts it in the top 2% of works published in 2023 by citations. It is open access under a CC BY licence: the full text is free to read at Advanced Science.

Citations
121
Most cited in
2026 (53)
Field-weighted impact
8.15
References
45
Authors
14

Abstract

PROteolysis TArgeting Chimeras (PROTACs) are an emerging class of promising therapeutic modalities that selectively degrade intracellular proteins of interest by hijacking the ubiquitin-proteasome system. However, the lack of techniques to efficiently transport these degraders to targeted cells and consequently the potential toxicity of PROTACs limit their clinical applications. Here, a strategy of nanoengineered PROTACs, that is, Nano-PROTACs, is reported, which improves the bioavailability of PROTACs and maximizes their capacity to therapeutically degrade intracellular oncogenic proteins for tumor therapy. The Nano-PROTACs are developed by encapsulating PROTACs in glutathione (GSH)-responsive poly(disulfide amide) polymeric (PDSA) nanoparticles and show that ARV@PDSA Nano-PROTAC, nanoengineered BRD4 degrader ARV-771, improves BRD4 protein degradation and decreases the downstream oncogene c-Myc expression. Benefiting from the GSH-scavenging ability to amply the c-Myc-related ferroptosis and cell cycle arrest, this ARV@PDSA Nano-PROTACs strategy shows superior anti-tumor efficacy with a low dose administration and good biocompatibility in vivo. The findings reveal the potential of the Nano-PROTACs strategy to treat a broad range of diseases by dismantling associated pathogenic proteins.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Liu, H., Chen, W., Wu, G., Zhou, J. M., LIU, C., Tang, Z., Huang, X., Gao, J., Xiao, Y., Kong, N., Joshi, N., Cao, Y., Abdi, R., & Tao, W. (2023). Glutathione‐Scavenging Nanoparticle‐Mediated PROTACs Delivery for Targeted Protein Degradation and Amplified Antitumor Effects. Advanced Science, 10(16), e2207439. https://doi.org/10.1002/advs.202207439

MLA 9

Liu, Haijun, et al. “Glutathione‐Scavenging Nanoparticle‐Mediated PROTACs Delivery for Targeted Protein Degradation and Amplified Antitumor Effects.” Advanced Science, vol. 10, no. 16, 2023, p. e2207439. https://doi.org/10.1002/advs.202207439.

Chicago

Liu, Haijun, Wei Chen, Gongwei Wu, Jun Min Zhou, Chuang LIU, Zhongmin Tang, Xiangang Huang, et al. 2023. “Glutathione‐Scavenging Nanoparticle‐Mediated PROTACs Delivery for Targeted Protein Degradation and Amplified Antitumor Effects.” Advanced Science 10 (16): e2207439. https://doi.org/10.1002/advs.202207439.

Harvard

Liu, H. et al. (2023) ‘Glutathione‐Scavenging Nanoparticle‐Mediated PROTACs Delivery for Targeted Protein Degradation and Amplified Antitumor Effects’, Advanced Science, 10(16), p. e2207439. doi:10.1002/advs.202207439.

IEEE

H. Liu et al., “Glutathione‐Scavenging Nanoparticle‐Mediated PROTACs Delivery for Targeted Protein Degradation and Amplified Antitumor Effects,” Advanced Science, vol. 10, no. 16, p. e2207439, 2023, doi: 10.1002/advs.202207439.

BibTeX

@article{liu2023glutathione,
  title     = {{Glutathione‐Scavenging Nanoparticle‐Mediated PROTACs Delivery for Targeted Protein Degradation and Amplified Antitumor Effects}},
  author    = {Liu, Haijun and Chen, Wei and Wu, Gongwei and Zhou, Jun Min and LIU, Chuang and Tang, Zhongmin and Huang, Xiangang and Gao, Jingjing and Xiao, Yufen and Kong, Na and Joshi, Nitin and Cao, Yihai and Abdi, Reza and Tao, Wei},
  journal   = {Advanced Science},
  year      = {2023},
  volume    = {10},
  number    = {16},
  pages     = {e2207439},
  doi       = {10.1002/advs.202207439},
  url       = {https://doi.org/10.1002/advs.202207439}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
202377
20242929
20253232
20265353

Its field-weighted citation impact is 8.15: it has been cited 8.15 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Degradation and Inhibitors

  • PROTACs
  • glutathione-responsive nanoparticles
  • targeted protein degradation
  • ubiquitin-proteasome system
  • BRD4 degradation
  • c-Myc
  • ferroptosis
  • cell cycle arrest

Work with this paper

Most-cited papers in Biochemistry, Genetics and Molecular Biology

All highly cited Biochemistry, Genetics and Molecular Biology papers

Questions about this paper

How do I cite this paper in APA style?

Liu, H., Chen, W., Wu, G., Zhou, J. M., LIU, C., Tang, Z., Huang, X., Gao, J., Xiao, Y., Kong, N., Joshi, N., Cao, Y., Abdi, R., & Tao, W. (2023). Glutathione‐Scavenging Nanoparticle‐Mediated PROTACs Delivery for Targeted Protein Degradation and Amplified Antitumor Effects. Advanced Science, 10(16), e2207439. https://doi.org/10.1002/advs.202207439

How many times has this paper been cited?

121 times, according to OpenAlex on 22 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at Advanced Science: sign in and open the PDF from this page.

Who wrote this paper?

Haijun Liu, Wei Chen, Gongwei Wu, Jun Min Zhou, Chuang LIU, Zhongmin Tang, Xiangang Huang, Jingjing Gao, Yufen Xiao, Na Kong, Nitin Joshi, Yihai Cao and 2 more.

What is the DOI of this paper?

10.1002/advs.202207439, permanently at https://doi.org/10.1002/advs.202207439. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 22 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.